Conn et al.
Article
contrast agents approved for human use are extracellular
2
4
fluid (ECF) gadolinium-based agents such as Magnevist. The
paramagnetic gadolinium(III) ion significantly reduces both the
longitudinal and transverse proton relaxation times (T and T )
1
2
25
relative to that of pure water. Because the free gadolinium(III) ion
has been shown to be toxic in both in vivo and in vitro studies,
it is generally sequestered by chelation or encapsulation
2
6-29
3
30-32
in
biomedical applications. Commercial contrast agents such as
Magnevist, which is the gadolinium complex of diethylenetri-
2
4
amine pentaacetic acid, are all nonspecific and suffer from the
shortcomings of limited resolution and relatively low inherent
3
3
sensitivity. Here we have investigated the use of self-assembled
34
gadolinium(III)-containing systems as MRI contrast agents. This
potentially allows us to access desirable properties of the self-
Figure 1. (A) Structure of phytanic acid, (B) an energy-minimized
molecular model for Gd(III) phytanate (including one water of
hydration), and (C) the putative hexagonal columnar structure of
Gd(III) phytanate. (B, C) Gd is green, O is red, and C is gray. For
clarity, H atoms have been omitted.
assembled system, for example, the capacity to encapsulate drugs,
35,36
along with sustained release and targeted delivery.
In addition,
self-assembled phases of lamellar, cubic, and hexagonal symmetry
can be dispersed in water to form nanoparticles known as lipo-
somes, cubosomes, and hexosomes, respectively. The aqueous
interior of these colloidal particles allows for the movement of
water into and out of the framework, and their high surface area
can accommodate large numbers of paramagnetic ions. In addi-
tion, their specificity can be enhanced by modification with target-
ing molecules. Such systems could additionally be used as contrast
agents for optical fluorescence imaging, for example, for terbium-
inverse micelles where the hydrophilic headgroups are arranged
toward water cores with hydrophobic chains radiating outward.
1
7
These micelles can pack into ordered cubic arrays or form an
entirely disordered packing resulting in a fluid inverse micellar
phase, the L phase. Intermediate and swollen spongelike phases
2
have also been identified in non-lamellar-forming lipid systems,
although to our knowledge these have not yet been identified for
(III) and europium(III) ions, which are luminescent in aqueous
1
8,19
metal-containing liquid crystals.
solution and generally retain their luminescence when bound to
37
Among the lanthanide salts of amphiphilic carboxylates and
alkanoates, most notable is thepublished work byBinnemans and
co-workers, where the thermotropic behavior and the effects of
chain length and lanthanide ion size on the mesophases of
complex ligand systems.
In this article, we present an investigation of the thermal
and lyotropic behavior of lanthanide phytanates, along with
an investigation into the utility of nanoparticulate dispersions
of lanthanide phytanates as potential contrast agents for
magnetic resonance imaging. Both unsaturation and branching
are known to promote mesophase formation because of the
reduction in van der Waals attraction forces in the chain
2
0,21
straight-chain alkanoates were studied.
It was found that
the lanthanide dodecanoates have a lamellar bilayer structure in
the solid state and that mesophases formed only for light
lanthanide ions having larger ionic radii. It has also been found
that various hydrates of the metal soap or the anhydrous
analogues can be formed by tuning the pH of the metathesis
reaction displacing sodium in the alkanoates with the lanthanide
2
2,38-41
region,
and we have previously investigated lanthanide
3
4
oleates with unsaturated hydrocarbon chains. Here we have
extended our research to include the phytanate chain, an
isoprenoid-type hydrocarbon chain with four methyl substi-
tuents along its saturated hydrocarbon backbone. The struc-
ture of phytanic acid is shown in Figure 1A. We also attempt to
understand the influence of metal ion size and valency on the
mesophase formed.
1
and also by varying the chain length. A study by Corkery
investigating the effects of curvature on the liquid crystallinity
of midchain branched fatty acid salts of transition metals and
lanthanide salts showed that the Cu, Zn, Sr, and Ba salts formed a
liquid-crystalline hexagonal columnar mesophase at room tem-
perature. An increase in hexagonal cell size with increasing ionic
2
2
radius was observed.
(
25) Meade, T. J.; Taylor, A. K.; Bull, S. R. Curr. Opin. Neurobiol. 2003, 13, 597.
(26) Biagi, B. A.; Enyeart, J. J. Am. J. Physiol. 1990, 259, C515.
27) Ergun, I.; Keven, K.; Uruc, I.; Ekmekci, Y.; Canbakan, B.; Erden, I.;
Karatan, O. Nephrol., Dial., Transplant. 2006, 21, 697.
28) Molgo, J.; del Pozo, E.; Banos, J. E.; Angaut-Petit, D. Br. J. Pharmacol.
1991, 104, 133.
Lanthanide salts of amphiphiles have the potential to be
efficient medical contrast agents with improved imaging capabil-
ities as well as featuring the ability to carry therapeutic “pay-
loads”. Contrast agents, used to increase the contrast between the
target organ and the surrounding tissues, are now used in over
(
(
(
29) Morcos, S. K. Catheterization Cardiovascular Interventions 2006, 68, 812.
(
30) Bolskar, R. D.; Benedetto, A. F.; Husebo, L. O.; Price, R. E.; Jackson, E.
2
3
3
5% of magnetic resonance imaging (MRI) diagnoses. Most
F.; Wallace, S.; Wilson, L. J.; Alford, J. M. J. Am. Chem. Soc. 2003, 125, 5471.
31) Kato, H.; Kanazawa, Y.; Okumura, M.; Taninaka, A.; Yokawa, T.;
(
Shinohara, H. J. Am. Chem. Soc. 2003, 125, 4391.
(
17) Seddon, J. M.; Zeb, N.; Templer, R. H.; McElhaney, R. N.; Mannock, D.
A. Langmuir 1996, 12, 5250.
18) Conn, C. E.; Ces, O.; Mulet, X.; Finet, S.; Winter, R.; Seddon, J. M.;
Templer, R. H. Phys. Rev. Lett. 2006, 96, 108102.
19) Mulet, X.; Gong, X.; Waddington, L. J.; Drummond, C. J. ACS Nano 2009,
, 2789.
(32) Sitharaman, B.; Kissell, K. R.; Hartman, K. B.; Tran, L. A.; Baikalov, A.;
Rusakova, I.; Sun, Y.; Khant, H. A.; Ludtke, S. J.; Chiu, W.; Laus, S.; Toth, E.;
Helm, L.; Merbach, A. E.; Wilson, L. J. Chem. Commun. 2005, 3915.
(33) Aime, S.; Cabella, C.; Colombatto, S.; Crich, S. G.; Gianolio, E.; Maggioni,
F. Magn. Reson. Imaging 2002, 16, 394.
(34) Liu, G.; Conn, C. E.; Drummond, C. J. J. Phys. Chem. B 2009, 113, 15949.
(35) Malmsten, M. Soft Matter 2006, 2, 760.
(
(
3
(
(
20) Jongen, L.; Binnemans, K.; Hinz, D.; Meyer, G. Liq. Cryst. 2001, 28, 1727.
21) Binnemans, K.; Jongen, L.; Gorller-Walrand, C.; D’Olieslager, W.; Hinz,
(36) Drummond, C. J.; Fong, C. Curr. Opin. Colloid Interface Sci. 1999, 4, 449.
(37) Richardson, F. S. Chem. Rev. 1982, 82, 541.
D.; Meyer, G. Eur. J. Inorg. Chem. 2000, 1429.
(
22) Corkery, R. W. Phys. Chem. Chem. Phys. 2004, 6, 1534.
(38) Attard, G. S.; West, Y. D. Liq. Cryst. 1990, 7, 487.
(
23) Aime, S.; Cabella, C.; Colombatto, S.; Crich, S. G.; Gianolio, E.; Maggioni,
(39) Maldivi, P.; Bonnet, L.; Giroudgodquin, A. M.; Ibnelhaj, M.; Guillon, D.;
F. J. Magn. Reson. 2002, 16, 394.
24) Pfeiffer, H.; Speck, U.; Renneke, F.; Hoyer, G.; Weinmann, H.; Rosenberg,
D.; Gries, H.; Mutzel, W.; Muetzel, W. NMR, X-ray and Ultrasonic Diagnostic
Compsns. - Contg. Salts of Metal Complexes, Including New Cpds; CA Patent
Skoulios, A. Adv. Mater. 1993, 5, 909.
(40) Sagnella, S.; Conn, C. E.; Krodkiewska, I.; Drummond, C. J. Soft Matter
2009, 5, 4823.
(
(41) Sagnella, S.; Conn, C. E.; Krodkiewska, I.; Moghaddam, M.; Seddon, J.
124069, Schering Ag (Schd), 1984.
M.; Drummond, C. J. Langmuir 2010, 10.1021/la903005q.
Langmuir 2010, 26(9), 6240–6249
DOI: 10.1021/la904006q 6241